TMS and DBS sit at opposite ends of the neuromodulation spectrum. TMS is completely non-invasive — walk in, sit down, walk out. DBS requires brain surgery. Electrodes get implanted deep in the brain, connected to a battery pack in the chest. One more thing: DBS for depression is investigational. It does not have FDA approval for depression (though it is approved for Parkinson’s disease, essential tremor, and dystonia).
What You’ll Learn
- How the mechanisms differ
- Why DBS is experimental for depression
- Risk comparison
- Efficacy comparison
- Treatment pathway — where each fits
How They Differ
TMS:
- Magnetic coil placed on the scalp
- Stimulates the cortical surface (~2-4cm deep)
- Outpatient, no anesthesia
- Temporary — effects last months, may need retreatment
- FDA-approved for depression since 2008
DBS:
- Electrodes surgically implanted into deep brain structures
- Stimulates specific deep brain nuclei continuously
- Requires brain surgery under general anesthesia
- Permanent implant with battery replacement every 3-5 years
- NOT FDA-approved for depression (experimental)
Efficacy
| Measure | TMS | DBS (experimental) |
|---|---|---|
| Response rate | 50-60% | 40-60% in trials |
| Remission rate | 30-35% | 20-40% in small studies |
| Speed of effect | 2-4 weeks | Weeks to months (requires tuning) |
| Durability | 6-12 months | Continuous (device always on) |
| Reversibility | Fully reversible | Somewhat reversible (device can be removed) |
Risk Comparison
TMS risks: Scalp discomfort, mild headache. Seizure risk under 0.01%. No lasting side effects.
DBS risks: Brain hemorrhage (2-5%), infection (3-5%), hardware malfunction, cognitive changes, speech difficulties, mood instability during programming. These are the risks that come with any brain surgery.
Where Each Fits in Treatment
The typical treatment escalation looks like this:
- Medications (2+ trials)
- Psychotherapy
- TMS — most people are here
- ECT
- VNS (implanted vagus nerve stimulator)
- DBS — last resort, experimental
DBS for depression is only offered at a handful of research centers worldwide. It’s for people who have failed everything else — TMS, ECT, VNS, multiple medications. We’re talking about the most treatment-resistant cases that exist.
TMS is safe, accessible, and FDA-approved — it’s tried relatively early when medications aren’t working. DBS is experimental, invasive, and a genuine last resort. Almost everyone should try TMS (and likely ECT and VNS) long before DBS would even be on the table.
Search for TMS providers or explore other device comparisons.
Key Takeaways
- TMS is non-invasive and FDA-approved for depression
- DBS is experimental, invasive, and not FDA-approved for depression
- DBS requires brain surgery with serious surgical risks
- TMS sits early in the treatment pathway; DBS is a last resort
- Most patients will never need to consider DBS
Find a TMS Clinic
Browse verified TMS providers, compare clinics, and find the right treatment for your situation.